Literature DB >> 20371616

Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.

Jiaoya Xi1, Markus Khalil, Nava Shishechian, Tobias Hannes, Kurt Pfannkuche, Huamin Liang, Azra Fatima, Moritz Haustein, Frank Suhr, Wilhelm Bloch, Michael Reppel, Tomo Sarić, Marius Wernig, Rudolf Jänisch, Konrad Brockmeier, Jürgen Hescheler, Frank Pillekamp.   

Abstract

Cardiomyocytes generated from embryonic stem cells (ESCs) and induced pluripotent stem (iPS) cells are suggested for repopulation of destroyed myocardium. Because contractile properties are crucial for functional regeneration, we compared cardiomyocytes differentiated from ES cells (ESC-CMs) and iPS cells (iPS-CMs). Native myocardium served as control. Murine ESCs or iPS cells were differentiated 11 d in vitro and cocultured 5-7 d with irreversibly injured myocardial tissue slices. Vital embryonic ventricular tissue slices of similar age served for comparison. Force-frequency relationship (FFR), effects of Ca(2+), Ni(2+), nifedipine, ryanodine, beta-adrenergic, and muscarinic modulation were studied during loaded contractions. FFR was negative for ESC-CMs and iPS-CMs. FFR was positive for embryonic tissue and turned negative after treatment with ryanodine. In all groups, force of contraction and relaxation time increased with the concentration of Ca(2+) and decreased with nifedipine. Force was reduced by Ni(2+). Isoproterenol (1 microM) increased the force most pronounced in embryonic tissue (207+/-31%, n=7; ESC-CMs: 123+/-5%, n=4; iPS-CMs: 120+/-4%, n=8). EC(50) values were similar. Contractile properties of iPS-CMs and ESC-CMs were similar, but they were significantly different from ventricular tissue of comparable age. The results indicate immaturity of the sarcoplasmic reticulum and the beta-adrenergic response of iPS-CMs and ESC-CMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371616     DOI: 10.1096/fj.09-145177

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

1.  Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.

Authors:  Nan Cao; Zumei Liu; Zhongyan Chen; Jia Wang; Taotao Chen; Xiaoyang Zhao; Yu Ma; Lianju Qin; Jiuhong Kang; Bin Wei; Liu Wang; Ying Jin; Huang-Tian Yang
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 2.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

Review 3.  Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.

Authors:  Issei S Shimada; Jeffrey L Spees
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

Review 4.  Scaffolds and cells for tissue regeneration: different scaffold pore sizes-different cell effects.

Authors:  Ieva Bružauskaitė; Daiva Bironaitė; Edvardas Bagdonas; Eiva Bernotienė
Journal:  Cytotechnology       Date:  2015-06-20       Impact factor: 2.058

5.  Cardiac regeneration using HLA-matched induced pluripotent stem cells-no monkey business, but still a long and winding road ahead.

Authors:  Daniel Sinnecker
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Genetic engineering of somatic cells to study and improve cardiac function.

Authors:  Robert D Kirkton; Nenad Bursac
Journal:  Europace       Date:  2012-11       Impact factor: 5.214

7.  Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease.

Authors:  W J de Lange; L F Hegge; A C Grimes; C W Tong; T M Brost; R L Moss; J C Ralphe
Journal:  Circ Res       Date:  2011-05-12       Impact factor: 17.367

8.  Reprogramming approaches in cardiovascular regeneration.

Authors:  Sophie Dal-Pra; Maria Mirotsou
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

Review 9.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

10.  Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.

Authors:  Hongran Wang; Yutao Xi; Yi Zheng; Xiaohong Wang; Austin J Cooney
Journal:  Stem Cell Res       Date:  2016-02-23       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.